Breckenridge Announces Approval for 40mg Duloxetine Delayed-release Capsules additional strength.

BOCA RATON, Fla., May 21, 2018 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today the supplemental approval for the 40mg strength of Duloxetine Delayed-Release Capsules. The U.S. Food and Drug Administration granted final approval for the Supplemental Abbreviated New Dr...